//-- 1-800-987-654 admin@totalwptheme.com User Login--// HOME ABOUT US PRODUCTS CAPABILITIES CAREERS CONTACT US Press Releases About Us Press Releases 29 APR 21 SPIRIT PHARMACEUTICALS ANNOUNCES EXCLUSIVE ANDA OTC PARTNERSHIP WITH UNIQUE PHARMACEUTICALS LTD./THINQ PHARMACEUTICALS, SINGAPORE Partnership includes ANDA OTC products including Cetirizine, Fexofenadine and Loratadine and other significant OTC products coming in the near future. PRESS RELEASE APR 5, 2021 13:00 EDT HAUPPAUGE, N.Y., April 5,… read more 22 AUG 18 SPIRIT PHARMACEUTICALS ANNOUNCES MAJOR LAUNCH OF NEW PRIVATE BRAND DOSAGE FORMS Ronkonkoma, NY, August 22, 2018 – Spirit Pharmaceuticals LLC., a global, leading supplier of Over the Counter (OTC) Pharmaceuticals, announces a significant portfolio expansion to their current line, which includes… read more 05 JUN 18 SPIRIT PHARMACEUTICALS NAMES NEW EXECUTIVE SENIOR DIRECTOR OF QA/RA AND STRATEGIC PLANNING Ronkonkoma, NY, June 5, 2018 – Spirit Pharmaceuticals LLC., a global, leading supplier of Over the Counter (OTC) Pharmaceuticals, announces the appointment Arati Deshpande as Senior Director of QA/RA and… read more Join Our Newsletter Sign up to receive timely, useful information in your inbox. Email * SPIRIT VENDOR CODE OF CONDUCT CHILD LABOR I MODERN DAY SLAVERY AND HUMAN TRAFFICKING I NO SOLICITATION I FREEDOM OF ASSOCIATION/COLLECTIVE BARGAINING OUR ETHICAL BUSINESS STANDARDS Copyright Spirit Pharmaceuticals LLC. 2021 - All Rights Reserved ×